Back to SGMT
UBS Group AG SGMT Position History
Sagimet Biosciences Inc. • Healthcare
Quarters held
15
Latest value
$3.3M
Q3 2026
Peak value
$3.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.8M |
| Q3 2025 | $227K |
| Q3 2025 | $70K |
| Q4 2025 | $1M |
| Q4 2025 | $146K |
| Q4 2025 | $10K |
| Q1 2026 | $954K |
| Q1 2026 | $574K |
| Q1 2026 | $8K |
| Q2 2026 | $1.3M |
| Q2 2026 | $1.3M |
| Q2 2026 | $39 |
| Q2 2026 | $8K |
| Q3 2026 | $1.1M |
| Q3 2026 | $3.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.3M | 333.5K | — | — |
| Q3 2026 | $1.1M | 107.4K | — | — |
| Q2 2026 | $8K | 1.0K | — | — |
| Q2 2026 | $39 | 5 | — | — |
| Q2 2026 | $1.3M | 165.3K | — | — |
| Q2 2026 | $1.3M | 173.6K | — | — |
| Q1 2026 | $8K | 1.5K | — | — |
| Q1 2026 | $574K | 109.8K | — | — |
| Q1 2026 | $954K | 182.7K | — | — |
| Q4 2025 | $10K | 1.6K | — | — |
| Q4 2025 | $146K | 24.7K | — | — |
| Q4 2025 | $1M | 175.4K | — | — |
| Q3 2025 | $70K | 10.2K | — | — |
| Q3 2025 | $227K | 33.1K | — | — |
| Q3 2025 | $1.8M | 263.5K | — | — |